Product Information
CELECOXIB 200 MG CAPSULE is a generic product labeled by ScieGen Pharmaceuticals, Inc., priced at $0.0762 per EA under NDC 50228015801. Its NADAC has been published 273 times since Jul 14, 2021.
FDA first approved this application on Dec 3, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
ScieGen Pharmaceuticals, Inc.NDC
50228015801
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CELECOXIBApproval Type
Generic (ANDA)
FDA Application
ANDA205129FDA Approved
12/3/2020
TE Code
AB
On Market Since
12/3/2020
Pharmacological Classes
Price Statistics
The NADAC for CELECOXIB 200 MG CAPSULE has been published 273 times since Jul 14, 2021, and over the history we have for it it has declined 53.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0762 per EA |
|---|---|
| All-time high | $0.1691 (Nov 10, 2021) |
| All-time low | $0.0758 (Nov 20, 2024) |
| 52-week high | $0.0880 |
| 52-week low | $0.0760 |
| Median price | $0.1071 |
| Average price | $0.1096 |
| Largest weekly change | +25.0% (Aug 21, 2024) |
| Weeks tracked | 273 |
| Tracking since | Jul 14, 2021 |
Generic Alternatives
The matcher finds 17 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ScieGen Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Celecoxib market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CELECOXIB 200 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CELECOXIB 200 MG CAPSULE, manufactured by ScieGen Pharmaceuticals, Inc., is $0.0762 per EA (NDC 50228015801), effective Sep 30, 2026.
How has the price of CELECOXIB 200 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CELECOXIB 200 MG CAPSULE has declined 53.9%. It has been tracked across 273 weekly CMS publications since Jul 14, 2021.
What are the highest and lowest recorded NADAC prices for CELECOXIB 200 MG CAPSULE?
Since Jul 14, 2021, the NADAC for CELECOXIB 200 MG CAPSULE has ranged from a low of $0.0758 (Nov 20, 2024) to a high of $0.1691 (Nov 10, 2021), with a median of $0.1071 per EA.
Are there cheaper alternatives to CELECOXIB 200 MG CAPSULE?
Yes. 17 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CELECOXIB 200 MG CAPSULE, is $0.0760 per EA — about 0% below CELECOXIB 200 MG CAPSULE.
Who manufactures CELECOXIB 200 MG CAPSULE?
CELECOXIB 200 MG CAPSULE (NDC 50228015801) is labeled by ScieGen Pharmaceuticals, Inc., and CMS classifies it as a generic product.